口香糖型藥物遞送系統市場規模、佔有率和成長分析：按藥物遞送類型、治療領域、活性成分、患者類型、最終用戶和地區分類－2026-2033年產業預測

2024 年全球口香糖型藥物輸送系統市值為 5 億美元，預計到 2033 年將從 2025 年的 5.43 億美元成長到 10.5061 億美元，預測期（2026-2033 年）的複合年成長率為 8.6%。

全球口香糖藥物遞送系統市場的特點是，產品將活性成分融入口香糖基質中，在咀嚼過程中釋放藥物。這項創新技術能夠在維持市售口香糖便利性的同時，實現藥物的可控吸收，從而提高患者依從性並避免首過效應。聚合物和香料技術的創新進步拓寬了配方選擇，使這個曾經的小眾領域發展成為一個價值數十億美元的產業。成長要素是對能夠提高用藥依從性和降低醫療成本的療法的需求不斷成長。隨著慢性病的日益增多，製造商正利用口香糖來遞送營養補充劑和低劑量藥物，以滿足人們對便利給藥方式的迫切需求。製藥公司和糖果甜點公司之間的合作日益增多，從而擴大了分銷網路，並加速了這個充滿活力的市場的收入成長。

全球口香糖型藥物傳輸系統市場促進因素

消費者對口香糖作為藥物輸送方式的接受度不斷提高，主要歸功於其便利性和隱藏的給藥方式，這與現代人的生活方式十分契合。由於這種給藥方式非侵入性且易於使用，使用者可以避免傳統藥物劑型造成的許多不便。因此，製造商積極拓展產品線，在不斷成長的需求和各個治療領域接受度的推動下，市場持續擴張。此外，由於活性成分可以融入人們熟悉的口香糖形式中，對於那些不願吞嚥藥片的人來說，藥物依從性得到了提升，這進一步增強了市場的潛力。

全球口香糖型藥物輸送系統市場的限制因素

口香糖式藥物輸送系統究竟應歸類為醫療設備還是複雜產品，這種模糊性導致監管路徑不明，需要提交詳盡的文件並接受多個監管機構的審查。滿足不同地區的標準差異會顯著延長產品上市時間，並增加合規成本。此外，安全性測試方案的不確定性可能導致重複申請流程，從而延遲產品上市。此類監管複雜性會阻礙小規模創新企業進入市場，最終減緩新產品上市速度，並限制整體市場成長。因此，潛在投資者可能對投資早期企業持謹慎態度。

口香糖型藥物傳輸系統的全球市場趨勢

全球口香糖藥物遞送系統市場正呈現出顯著的個人化醫療趨勢，這主要得益於消費者對便捷易用的給藥方式的需求。隨著人們越來越傾向於選擇能夠無縫融入日常生活的解決方案，製造商正不斷創新，將各種藥物活性成分融入口香糖基質中。改良的掩味技術和緩釋聚合物的應用，使得個人化的藥物釋放曲線成為可能，從而滿足不同的治療需求，例如緩解急性疼痛和慢性疾病管理。這一趨勢正在將口香糖打造成為一個多功能平台，以彌合生活方式產品和處方藥之間的鴻溝，滿足當今注重健康的消費者的需求。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球口香糖型藥物輸送系統市場規模：依藥物輸送類型分類

• 立即發布
• 可控放電型
• 緩釋型

全球口香糖型藥物傳輸系統市場規模：依治療領域分類

• 疼痛管理
• 禁止抽煙
• 口腔清潔用品
• 消化器官系統疾病

全球口香糖型藥物傳輸系統市場規模：依活性成分分類

• 尼古丁
• 止痛藥
• 維生素和營養素
• 其他活性成分

全球口香糖型藥物輸送系統市場規模：依病患類型分類

• 成人
• 兒童患者

全球口香糖型藥物輸送系統市場規模：依最終用戶分類

• 醫院和診所
• 藥局
• 居家照護

全球口香糖型藥物輸送系統市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要公司簡介

• Fertin Pharma A/S
• Leaf Holland BV
• Medicated Chewing Gum
• Pharmalink SL
• Nicobrand Limited
• Fertin Pharma
• Keller & Heckman LLP
• Roquette Freres
• Lonza Group AG
• Catalent, Inc.
• Kenvue Inc.
• Haleon plc
• Perrigo Company plc
• Reckitt Benckiser Group plc
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• GlaxoSmithKline plc
• Nicotinell
• Nicorette

結論與建議

Global Chewing Gum Drug Delivery System Market size was valued at USD 500.0 Million in 2024 and is poised to grow from USD 543.0 Million in 2025 to USD 1050.61 Million by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).

The global chewing gum drug delivery system market features products that incorporate active pharmaceutical ingredients into gum bases, enabling therapeutic release during chewing. This innovation offers the convenience of over-the-counter gum while ensuring controlled drug absorption, thereby enhancing patient compliance and circumventing first-pass metabolism. Innovative advances in polymer and flavor technology have broadened formulation options, transforming this once niche segment into a billion-dollar industry. The main growth driver stems from the increasing demand for therapies that facilitate adherence and lower healthcare expenses. As chronic diseases rise, manufacturers are utilizing gum to deliver nutraceuticals and low-dose medications, responding to the pressing need for convenient dosing. Partnerships between pharmaceutical and confectionery companies are emerging, expanding distribution and accelerating revenue growth in this dynamic market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chewing Gum Drug Delivery System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chewing Gum Drug Delivery System Market Segments Analysis

Global chewing gum drug delivery system market is segmented by drug delivery type, therapeutic area, active ingredient, patient type, end user and region. Based on drug delivery type, the market is segmented into Immediate-Release, Controlled-Release and Sustained-Release. Based on therapeutic area, the market is segmented into Pain Management, Smoking Cessation, Oral Healthcare and Gastrointestinal Disorders. Based on active ingredient, the market is segmented into Nicotine, Analgesics, Vitamins & Nutrients and Other Active Ingredients. Based on patient type, the market is segmented into Adults and Pediatric Patients. Based on end user, the market is segmented into Hospitals & Clinics, Pharmacies and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Chewing Gum Drug Delivery System Market

The increasing consumer acceptance of chewing gum as a method for medication delivery is largely influenced by its convenient and discreet administration, which resonates well with contemporary lifestyle choices. This type of delivery is viewed as non-invasive and easy to use, allowing users to bypass many of the challenges linked to traditional medication forms. As a result, manufacturers are motivated to broaden their product ranges, leading to greater market growth driven by rising demand and wider acceptance across various therapeutic sectors. Additionally, the ability to incorporate active ingredients into a familiar format promotes adherence among individuals averse to swallowing pills, further enhancing market potential.

Restraints in the Global Chewing Gum Drug Delivery System Market

The classification of chewing gum drug delivery systems as either medical devices or combination products results in unclear regulatory pathways, necessitating comprehensive documentation and reviews from various agencies. Navigating the diverse standards across regions can significantly extend the time required to bring products to market and increase compliance expenses. Additionally, ambiguity surrounding safety testing protocols may result in repeated submission processes, hindering timely product launches. This regulatory intricacy can deter smaller innovators from entering the market, ultimately slowing the introduction of new products and limiting overall market growth. As a result, potential investors may become reluctant to finance early-stage endeavors.

Market Trends of the Global Chewing Gum Drug Delivery System Market

The Global Chewing Gum Drug Delivery System market is witnessing a significant trend toward personalized therapeutics, driven by consumer demand for convenient and familiar dosage forms. As individuals increasingly prefer solutions that seamlessly integrate into their daily routines, manufacturers are innovating by incorporating a diverse range of active pharmaceutical ingredients into gum matrices. Enhanced taste-masking technologies and controlled-release polymers enable tailored release profiles to address various therapeutic needs, such as acute pain relief and chronic disease management. This trend positions chewing gum as a versatile platform that bridges the gap between lifestyle products and prescription-grade drug delivery, catering to the needs of health-conscious consumers in contemporary markets.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Chewing Gum Drug Delivery System Market Size by Drug Delivery Type & CAGR (2026-2033)

• Market Overview
• Immediate-Release
• Controlled-Release
• Sustained-Release

Global Chewing Gum Drug Delivery System Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Pain Management
• Smoking Cessation
• Oral Healthcare
• Gastrointestinal Disorders

Global Chewing Gum Drug Delivery System Market Size by Active Ingredient & CAGR (2026-2033)

• Market Overview
• Nicotine
• Analgesics
• Vitamins & Nutrients
• Other Active Ingredients

Global Chewing Gum Drug Delivery System Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Adults
• Pediatric Patients

Global Chewing Gum Drug Delivery System Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Pharmacies
• Homecare

Global Chewing Gum Drug Delivery System Market Size & CAGR (2026-2033)

• North America (Drug Delivery Type, Therapeutic Area, Active Ingredient, Patient Type, End User)
  • US
  • Canada
• Europe (Drug Delivery Type, Therapeutic Area, Active Ingredient, Patient Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Delivery Type, Therapeutic Area, Active Ingredient, Patient Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Delivery Type, Therapeutic Area, Active Ingredient, Patient Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Delivery Type, Therapeutic Area, Active Ingredient, Patient Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Fertin Pharma A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leaf Holland B.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicated Chewing Gum
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmalink S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nicobrand Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fertin Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keller & Heckman LLP
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kenvue Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haleon plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nicotinell
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nicorette
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations